Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/154
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paula, Braitstein | - |
dc.contributor.author | Siika, Abraham | - |
dc.contributor.author | Hogan, Joseph | - |
dc.contributor.author | Kosgei, Rose | - |
dc.contributor.author | Sang, Edwin | - |
dc.contributor.author | Sidle, John | - |
dc.contributor.author | Wools-Kaloustian, Kara | - |
dc.contributor.author | Keter, Alfred | - |
dc.contributor.author | Mamlin, Joseph | - |
dc.contributor.author | Kimaiyo, Sylvester | - |
dc.date.accessioned | 2017-10-04T13:17:24Z | - |
dc.date.available | 2017-10-04T13:17:24Z | - |
dc.date.issued | 2012-02 | - |
dc.identifier.uri | https://www.biomedcentral.com/1758-2652/content/15/1/7 | - |
dc.identifier.uri | http://ir.mu.ac.ke:8080/xmlui/handle/123456789/154 | - |
dc.description.abstract | Background: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. Methods: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm3. All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm3 were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. Results: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm3. After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). Conclusions: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings. | en_US |
dc.description.sponsorship | The USAID-AMPATH Rockefeller Foundation Kenyan National Leprosy,Tuberculosis, and Lung Disease (NLTLD) Programme | en_US |
dc.language.iso | en | en_US |
dc.publisher | Journal of the International AIDS Society | en_US |
dc.subject | Antiretrovirals | en_US |
dc.subject | Mortality | en_US |
dc.subject | Losses to follow up | en_US |
dc.subject | Adherence | en_US |
dc.subject | Models of care | en_US |
dc.subject | Africa | en_US |
dc.title | A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.